|
|
|
1,001-5,000 employees
View all
|
|
biotechnology
|
|
215 First Street,Cambridge,MA,US
|
|
Sarepta Therapeutics, headquartered in Cambridge, Massachusetts, is a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to treat rare diseases. Sarepta is at the forefront of precision genetic medicine, having built an impressive and competitive position in Duchenne muscular dystrophy (DMD) and more recently in Limb-girdle muscular dystrophy (LGMD), Charcot-Marie-Tooth (CMT) and CNS-related disorders, reaching a total of over 20 therapies in various stages of development. The Company’s programs span across several therapeutic modalities, including RNA, gene therapy and gene editing. Sarepta is poised to be the most meaningful precision genetic medicine company in the world and make a profound difference in the lives of patients suffering from rare neuromuscular diseases and other rare diseases. For more information, please visit www.sarepta.com.
|
Sarepta Therapeutics Email Formats | Example Email Formats | Percentage |
---|---|---|
{f}{last} | [email protected] |
72.73%
|
The widely used Sarepta Therapeutics email format is {f}{last} (e.g. [email protected]) with 72.73% adoption across the company.
To contact Sarepta Therapeutics customer service number in your country click here to find.
Douglas S Ingram is the CEO of Sarepta Therapeutics. To contact Douglas S Ingram email at [email protected].
Find accurate personal emails, work emails and phone numbers for employees
Accelerate prospecting with instant access to 300M professionals from 30M companies with the right contact details.